Announcements Trials

Browse Landscape

Phase

Phase 3 1 Phase 2 1 Phase 1/2 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 630 Triple Negative Breast Neoplasms 166 Ovarian Neoplasms 103 Carcinoma, Non-Small-Cell Lung 100 Neoplasm Metastasis 76 Colorectal Neoplasms 64 Melanoma 61 Stomach Neoplasms 60 Neoplasms 56 Pancreatic Neoplasms 55 Squamous Cell Carcinoma of Head and Neck 50 Prostatic Neoplasms 48 Endometrial Neoplasms 48 Lung Neoplasms 47 Uterine Cervical Neoplasms 36 Carcinoma, Renal Cell 35 Sarcoma 33 Head and Neck Neoplasms 33 Esophageal Neoplasms 32 Breast Neoplasms, Male 29 Urinary Bladder Neoplasms 26 Small Cell Lung Carcinoma 26 Colonic Neoplasms 26 Carcinoma, Transitional Cell 23 Carcinoma, Ovarian Epithelial 21 Lymphoma 18 Brain Neoplasms 18 Kidney Neoplasms 17 Carcinoma, Hepatocellular 17 Liver Neoplasms 15

Interventions

pembrolizumab 1 exemestane 1 Leuprolide 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Premenopausal Breast Cancer × Breast × Clear all

NCT02990845 2023-02-22

PEER

National Taiwan University Hospital

Phase 1/2 Terminated

Premenopausal Breast Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡